Current Report Filing (8-k)
11 Aprile 2023 - 10:01PM
Edgar (US Regulatory)
0001482541
false
0001482541
2023-04-11
2023-04-11
0001482541
CEAD:CommonStock0.00001ParValueMember
2023-04-11
2023-04-11
0001482541
CEAD:WarrantsToPurchaseCommonStockMember
2023-04-11
2023-04-11
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
Current
Report Pursuant to Section 13 or 15(d) of
the
Securities Exchange Act of 1934
Date
of Report (Date of earliest event reported):
April
11, 2023
CEA
INDUSTRIES INC.
(Exact
name of registrant as specified in its charter)
| Nevada |
|
001-41266 |
|
27-3911608 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(I.R.S.
Employer
Identification
No.) |
385
South Pierce Avenue, Suite C
Louisville,
Colorado 80027
(Address
of principal executive offices and zip code)
Registrant’s
telephone number, including area code: (303) 993-5271
Check
the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of
the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Exchange Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Common
Stock, $0.00001 par value |
|
CEAD |
|
Nasdaq
Capital Market |
| Warrants
to purchase Common Stock |
|
CEADW |
|
Nasdaq
Capital Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
On
April 10, 2023, CEA Industries Inc. (the “Company”) received a letter from the Listing Qualifications Department of the Nasdaq
Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the 30
consecutive business day period between February 24, 2023, through April 6, 2023, the Company did not meet the minimum bid price of $1.00
per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated
that the Company will be provided with a compliance period of 180 calendar days, or until October 9, 2023 (the “Compliance Period”),
in which to regain compliance pursuant to Nasdaq Listing Rule 5810(c)(3)(A).
In
order to regain compliance with Nasdaq’s minimum bid price requirement, the Company’s common stock must maintain a minimum
closing bid price of $1.00 for at least ten consecutive business days during the Compliance Period. In the event the Company does not
regain compliance by the end of the Compliance Period, the Company may be eligible for additional time to regain compliance. To qualify
for the additional time, the Company will be required to meet the continued listing requirement for the market value of its publicly
held shares and all the other listing standards for The Nasdaq Capital Market and will need to provide written plan to cure the deficiency
during the second compliance period. The Company may be granted an additional 180 calendar days to regain compliance if the plan is accepted
by Nasdaq. However, if it appears to Nasdaq that the Company will be unable to cure the deficiency, or if the Company is not otherwise
eligible for the additional cure period, Nasdaq will provide notice that the Company’s common stock will be subject to delisting.
The
letter has no immediate impact on the listing of the Company’s common stock, which will continue to be listed and traded on The
Nasdaq Capital Market, subject to the Company’s compliance with the other listing requirements of The Nasdaq Capital Market.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
| Date:
April 11, 2023 |
CEA
INDUSTRIES INC. |
| |
|
|
| |
By |
/s/
Anthony K. McDonald |
| |
|
Anthony
K. McDonald |
| |
|
President
and Chief Executive Officer |
Grafico Azioni CEA Industries (NASDAQ:CEAD)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni CEA Industries (NASDAQ:CEAD)
Storico
Da Nov 2023 a Nov 2024
